Well - hack Mueller's First Botched Investigation <

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
87
Well - hack Mueller's First Botched Investigation
< >

Controversy surrounds Robert Mueller and his investigation into the Trump-Russia collusion mirage. Some maintain that he is the ultimate professional dedicated to following the truth, but others say he is a political hack.

There is no need to wonder about how Mueller operates. His history has made it quite clear. One needs only to study his actions as FBI director when he managed the FBI's most important investigation ever.

In September of 2001, an entity began mailing anthrax through the U.S. postal system, hitting such prominent targets as NBC and Senator Tom Daschle's office. The terrorist attacks killed five and left others hospitalized. The world panicked.

Under Mueller's management, the FBI launched an investigation lasting ten years. The bureau now brags about spending "hundreds of thousands of investigator hours on this case." To fully appreciate the Mueller response – whom his people investigated, targeted, and found guilty – it is appropriate to first build context.

The anthrax letters began just a week after the 9/11 attack. Simultaneous to planning the airplane hijackings, al-Qaeda had also been weaponizing anthrax. One of their scientists who ran an anthrax lab in Afghanistan also housed 9/11 hijackers. In fact, one of the hijackers, Ahmed al Haznawi, went to the emergency room in an American hospital with a skin lesion, which a team of bioterrorism experts from Johns Hopkins confirmed was probably due to anthrax. Meanwhile, the 9/11 hijackers were also trying to obtain crop-dusting airplanes.


So how did Mueller's investigative team handle the case?

Mueller issued a statement in October of 2001, while anthrax victims were still dying: the FBI had found "no direct link to organized terrorism." The Johns Hopkins team of experts was mistaken, the FBI continued; Haznawi never had an anthrax infection. The crop-dusting airplanes they needed were possibly for a separate and unrelated anthrax attack.

A few weeks later, the FBI released a remarkable profile of the attacker. FBI experts eschewed analysis of the content of the letters, where it was written in bold block letters, "Death to America, Death to Israel, Allah is Great." Instead, they focused on a "linguistic analysis," stating that the letter's author was not "comfortable or practiced in writing in lower[]case lettering." They therefore concluded that the author was likely an American.

The investigators hypothesized that the attacker was a lonely American who had wanted to kill people with anthrax for some undefined time period but then became "mission-oriented" following 9/11 and immediately prepared and mailed the deadly spores while pretending to be Muslim.

Mueller's FBI honed in on Steven Hatfill – a "flag-waving" American who had served in the Army, then dedicated himself to protecting America from bioterrorist threats by working in the United States Army Medical Research Institute of Infectious Diseases – as the culprit.

There was no direct link from Hatfill to the attacks, by the FBI's own admission. The FBI never even charged Hatfill.

The bureau only spied on, followed, and harassed him, non-stop, for years. The Department of Justice publicly outed Hatfill as the possible terrorist.

While America's secret police trampled on Hatfill's dignity and life, Mueller took a stand – but on a different topic. He made front-page news for threatening President George W. Bush with resignation over NSA policy – all while his own team was destroying the rights of an American in the FBI's largest ever investigation.

Hatfill successfully sued the government for its unlawful actions. He won almost six million dollars.

After the Hatfill investigation blew up in the FBI's face, the agents moved on to Bruce Ivins, another Army researcher. Ivins had actually been helping the FBI for years after having gone out of his way to contact the FBI to volunteer his expertise. It wasn't until five years after the attack that Mueller's men decided that Ivins was a target.

The FBI case against Ivins was, once again, based on circumstantial evidence.

The prosecution stated that Ivins had purposefully given a misleading sample of anthrax spore. Frontline documented that this was a lie.
Ivins was "familiar" with the area from which the anthrax letters were mailed – even though Pulitzer Prize-winning ProPublica lays out the accepted facts of the case, showing that it was impossible for Ivins to make the trip to mail the letters.
The spores used in the attacks were a similar type to the laboratory spores where Ivins worked – which ignores the fact that the anthrax letters had a unique additive, so sophisticated and dangerous that a scientist commented, "This is not your mother's anthrax," that was likely produced by a nation-state or al-Qaeda.
Ivins was never indicted. He was just given the Hatfill treatment: house raided and threatened with a death sentence, or, as his lawyer put it, put under "relentless pressure of accusation and innuendo." He committed suicide.

One week later, U.S. Attorney Jeffrey Taylor stated that Ivins was guilty "beyond a reasonable doubt," and law enforcement was "confident that Dr. Ivins was the only person responsible for these attacks."

Director Mueller ordered an independent audit of the FBI's case by the National Academy of Science but then quietly closed the case before the audit was finished. Mueller concluded that Ivins alone committed the terror attack. One year after Mueller closed the case, the NAS released its results and confirmed what many scientists had been repeating for years: the FBI's science and conclusions were wrong.

The handling of the case was so egregious that a former FBI official involved in the investigation sued the FBI, alleging that the FBI had concealed evidence exculpatory to Ivins.

Mueller made his position known – "I do not apologize for any aspect of this investigation" – and stated that the FBI had made no mistakes.

The investigation was an unmitigated disaster for America. Mueller didn't go after al-Qaeda for the anthrax letters because he denied seeing a direct link. But then he spent years abusing Americans without showing a direct link.

Mueller enjoyed the second longest tenure of any FBI director and was roundly applauded by nearly everyone (except Louie Gohmert). For his behavior he was also awarded special counsel status to go after Donald Trump, in a process where, still, no one has any idea what specific crimes are even alleged. There is every reason to think he will handle his most important investigation the same way he handled his second most important investigation. We can safely predict that it will be a prolonged, abusive, and politically correct attack. Actually, that isn't even a prediction of the future. It has already become a mere explanation of the past nigh year.

Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Virse Revolutionizes Creative Production with AI Canvas

Updated Category News Views 156

A New Era in Creative Workflows These days, the design world is getting a major shake-up thanks to Virse's innovative AI-driven workspace. Based out of Dover, this new system isn't just about boosting tech for the sake of it; it's about making creative production a symphony rather than a cacophony. And, let me tell ya, any time I've loaded up on coffee to prep for a brand...

Continue Reading
MPLX Reports Q3 2026 Results with 12.5% Distribution Hike

Updated Category News Views 34

Another Distribution Hike: 12.5% Bump in Q3 Man, MPLX is at it again, boosting that quarterly distribution by a hefty 12.5%. That's three years running now, marking it up to $4.84 per unit on an annualized basis. In an industry where reliability sometimes feels like a relic, this kind of consistency is a sweet serenade to any income-focused investor's ears. "MPLX is...

Continue Reading
Newcomers, Veterans Elevate NYSE's Tokenization Efforts

Updated Category News Views 100

Breaking New Ground at the NYSE When the bell rings at the NYSE these days, it's not just marking the start of another trading session. It's the sound of change clanging its way onto Wall Street. On November 3, 2026, the NYSE threw its hat deeper into the tokenization ring, a game-changer perhaps. They've roped in some big guns—Securitize, tZERO, Broadridge Financial...

Continue Reading
Lupin Launches HIV Treatment, Secures 180-Day Exclusivity

Updated Category News Views 18

Lupin's Market Move: A Big Step in HIV Treatment There's a fresh gust blowing in the pharmaceutical skies today, as Lupin leaps ahead with the launch of their Raltegravir Tablets in the U.S. The company just bagged FDA approval, putting them on the front lines with a high-stake 180-day exclusivity period for their generic version. For investors keeping tabs on pharma...

Continue Reading
Canton Fair Showcases Cutting-Edge Healthcare Tech 2026

Updated Category News Views 41

Innovation Steals the Show in Guangzhou In a world where tech evolution rarely takes a breather, the 140th Canton Fair's Intelligent Healthcare Zone is like a breath of fresh air. Picture it: a whole arena pulsing with futuristic healthcare gizmos from October 31 to November 4, 2026—it's as if tomorrow swung by for a sneak peek. The event brings together everything from...

Continue Reading
Yunji Rolls Out AI Robots at EquipHotel Paris 2026

Updated Category News Views 90

AI Takes Center Stage in Hospitality When someone mentions a new revolution in hospitality, I usually roll my eyes. But this time, Yunji Technology (HKEX: 02670) is bringing something to the table that's hard to ignore. They’re out in full force at EquipHotel Paris 2026, flaunting their AI-powered collection of service bots with the kind of confidence that says, 'We're...

Continue Reading
Reju Partners with Six Mills to Advance Textile Regeneration

Updated Category News Views 203

Big Moves in Textile Regeneration Now here's a move that's got the fabric world buzzing: Reju, the scrappy textile-to-textile regenerative powerhouse, is teaming up with six mills spread across Europe and the U.S. They’re setting the stage to crank up their polyester recycling game and flood the market with sustainable, eco-friendly fabrics. It's a bold step toward...

Continue Reading
Himel's Latest: Powering Industry and Homes Alike

Updated Category News Views 46

Switching Gears: Himel's New Electrical Frontiers Ah, the humming of motors, the click of switches—it's the backbone of any decent industrial setup or modern home today. Himel isn't messing around when it comes to staying on top of these evolving electrical needs, both in gritty industrial settings and our cozy living rooms. This time, they're taking a serious crack at...

Continue Reading
XPENG Eyes South Korea Entry with Industry Veteran

Updated Category News Views 142

A Veteran's Task in a New Territory Piling onto its international ambitions, XPENG has roped in Lee Man-sik, a seasoned auto industry professional, to break into South Korea. South Korea isn’t just another market—it’s one of the toughest stages for the automotive industry. The customers there are sharp, with a keen eye for tech and quality. So XPENG, trading under...

Continue Reading
Samsung Biologics Hits 'Negligible' ESG Risk Milestone

Updated Category News Views 26

Samsung Biologics Achieves a Low-Risk Triumph You gotta hand it to Samsung Biologics for hitting a 'Negligible Risk' rating. Their latest score? A cool 9.0. That’s like walking into the pharmaceuticals room and getting a standing ovation. It's no small feat—climbing up from a 'Low Risk' rating to the top tier in Morningstar Sustainalytics' playbook. For us spectating...

Continue Reading

Top 5 Most Recently Viewed Articles

EnFin Solar Receivables Trust Receives Ratings from KBRA

Updated Category News Views 525

EnFin Residential Solar Receivables Trust 2024-2 Overview Recently, KBRA has assigned preliminary ratings to three classes of notes that total $324.54 million, issued by EnFin Residential Solar Receivables Trust 2024-2, commonly referred to as EnFin 2024-2. This asset-backed securities (ABS) transaction is secured by residential solar loans, aiming to support solar energy...

Continue Reading
Taxbit's Digital Accord to Shape Future of Compliance

Updated Category News Views 257

Taxbit's Digital Accord: Building a Future in Compliance The third edition of the Digital Accord gathers influential regulators and innovators to strategize the future of digital asset compliance and transparency. Global Leaders Meet in London Gathered in this major global capital, executives from various sectors will dive deep into the essential frameworks that will...

Continue Reading
Centene Corporation Q1 2025 Report Showcases Strong Growth

Updated Category News Views 588

Centene Corporation Reports Strong First Quarter 2025 Results Centene Corporation (NYSE: CNC) has made a notable impact in the healthcare sector, showcasing impressive financial achievements in its first-quarter results. The company reported adjusted diluted EPS of $2.90 for the quarter, reflecting a substantial increase of 28% from $2.26 in the same quarter the previous...

Continue Reading
Theratechnologies Faces Temporary EGRIFTA SV Supply Challenges

Updated Category News Views 111

Theratechnologies Faces Temporary Challenges with EGRIFTA SV Supply MONTREAL - Theratechnologies Inc. (NASDAQ: THTX), a well-known biopharmaceutical company, is currently tackling a potential supply interruption regarding its product EGRIFTA SV. This situation has arisen from an unexpected shutdown at a contract manufacturer’s facility, which followed an FDA inspection....

Continue Reading
Miami International Holdings Achieves Record Trading Figures

Updated Category News Views 281

Overview of Trading Results Miami International Holdings, Inc. (MIH) has recently shared its impressive trading results for December and the entire year of 2024, showcasing strong performance across its U.S. exchange subsidiaries including MIAX, MIAX Pearl, MIAX Emerald, and MIAX Sapphire, as well as MIAX Futures. December 2024 and Full-Year Volume Highlights The overall...

Continue Reading